Literature DB >> 29221239

Inflammatory status and prognosis of locally advanced non-small cell lung cancer.

José María Galvan-Roman1, José Curbelo2, Javier Aspa3.   

Abstract

Entities:  

Year:  2017        PMID： 29221239      PMCID： PMC5708461          DOI： 10.21037/jtd.2017.08.27

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  25 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  Immunological Status May Predict Response to Nivolumab in Non-small Cell Lung Cancer without Driver Mutations.

Authors:  Makoto Nakao; Hideki Muramatsu; Yusuke Kagawa; Yuto Suzuki; Yusuke Sakai; Ryota Kurokawa; Kohei Fujita; Hidefumi Sato
Journal:  Anticancer Res       Date:  2017-07       Impact factor: 2.480

3.  Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality Therapy.

Authors:  Katherine A Scilla; Søren M Bentzen; Vincent K Lam; Pranshu Mohindra; Elizabeth M Nichols; Melissa A Vyfhuis; Neha Bhooshan; Steven J Feigenberg; Martin J Edelman; Josephine L Feliciano
Journal:  Oncologist       Date:  2017-05-22

4.  Association of intra-tumoral tumour-infiltrating lymphocytes and neutrophil-to-lymphocyte ratio is an independent prognostic factor in non-small cell lung cancer.

Authors:  Nigar Dirican; Yeliz Arman Karakaya; Sedat Gunes; Ferah Tuncel Daloglu; Ahmet Dirican
Journal:  Clin Respir J       Date:  2015-12-28       Impact factor: 2.570

5.  Persistent lymphocytopenia as a diagnostic feature of bronchogenic carcinoma.

Authors:  L J McMahon; S P Thomson; C A Nugent; W F Denny; T P Miller
Journal:  Chest       Date:  1980-10       Impact factor: 9.410

Review 6.  IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis.

Authors:  Julia Bollrath; Florian R Greten
Journal:  EMBO Rep       Date:  2009-11-06       Impact factor: 8.807

7.  Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas.

Authors:  Isabelle Ray-Coquard; Claire Cropet; Martine Van Glabbeke; Catherine Sebban; Axel Le Cesne; Ian Judson; Olivier Tredan; Jaap Verweij; Pierre Biron; Inthidar Labidi; Jean-Paul Guastalla; Thomas Bachelot; David Perol; Sylvie Chabaud; Pancras C W Hogendoorn; Philippe Cassier; Armelle Dufresne; Jean-Yves Blay
Journal:  Cancer Res       Date:  2009-06-23       Impact factor: 12.701

Review 8.  Mechanism of Action of IL-7 and Its Potential Applications and Limitations in Cancer Immunotherapy.

Authors:  Jianbao Gao; Lintao Zhao; Yisong Y Wan; Bo Zhu
Journal:  Int J Mol Sci       Date:  2015-05-06       Impact factor: 5.923

9.  Perioperative neutrophil:lymphocyte ratio and postoperative NSAID use as predictors of survival after lung cancer surgery: a retrospective study.

Authors:  Jae Eun Choi; John Villarreal; Javier Lasala; Vijaya Gottumukkala; Reza J Mehran; David Rice; Jun Yu; Lei Feng; Juan P Cata
Journal:  Cancer Med       Date:  2015-03-10       Impact factor: 4.452

Review 10.  Neutrophil extracellular traps in cancer progression.

Authors:  Jonathan Cools-Lartigue; Jonathan Spicer; Sara Najmeh; Lorenzo Ferri
Journal:  Cell Mol Life Sci       Date:  2014-07-29       Impact factor: 9.261
View more
  1 in total

1.  MicroRNA-139-5p regulates chronic inflammation by suppressing nuclear factor-κB activity to inhibit cell proliferation and invasion in colorectal cancer.

Authors:  Mingming Zhu; Wen Zhang; Jun Ma; Youguo Dai; Qi Zhang; Qin Liu; Burong Yang; Gang Li
Journal:  Exp Ther Med       Date:  2019-09-20       Impact factor: 2.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.